Trials / Unknown
UnknownNCT06275334
Dinutuximab Beta at the HUS and the Toulouse Oncopole
Dinutuximab Beta at the Strasbourg University Hospitals (HUS) and the Toulouse Oncopole: Comparative Analysis of Patient Pathways, Associated Costs and Quality of Life According to Traditional Hospitalization or Hospital at Home (HAD)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 2 Years – 25 Years
- Healthy volunteers
- —
Summary
In this study the investigators wish to describe the cohort of pediatric patients suffering from neuroblastoma and treated with Dinutuximab and to compare the costs and quality of life between the two French centers, the University Hospital of Strasbourg (HUS) and the Oncopole of Toulouse.
Conditions
Timeline
- Start date
- 2023-11-28
- Primary completion
- 2024-11-01
- Completion
- 2024-11-28
- First posted
- 2024-02-23
- Last updated
- 2024-02-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06275334. Inclusion in this directory is not an endorsement.